Jian Jun Li

Summary

Country: China

Publications

  1. pmc Increased red cell distribution width in patients with slow coronary flow syndrome
    Song Hui Luo
    Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Division of Cardiology, State Key Laboratory of Cardiovascular Disease, Beijing China
    Clinics (Sao Paulo) 68:732-7. 2013
  2. pmc Evaluation of red blood cell distribution width in patients with cardiac syndrome X
    Ping Qing
    Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Dis Markers 34:333-9. 2013
  3. pmc RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies
    Jun Liu
    Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    PLoS ONE 7:e47211. 2012
  4. ncbi Inflammation in coronary artery diseases
    Jian Jun Li
    Divison of Dyslipidemia, Cardiovascular Medicine, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 124:3568-75. 2011
  5. doi Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Coron Artery Dis 20:65-70. 2009
  6. ncbi Is any link between inflammation and coronary artery ectasia?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 69:678-83. 2007
  7. doi Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P R China
    Ann Med 42:231-40. 2010
  8. ncbi Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 120:569-73. 2007
  9. ncbi Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People s Republic of China
    Coron Artery Dis 18:293-8. 2007
  10. ncbi Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 69:333-7. 2007

Collaborators

Detail Information

Publications93

  1. pmc Increased red cell distribution width in patients with slow coronary flow syndrome
    Song Hui Luo
    Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Division of Cardiology, State Key Laboratory of Cardiovascular Disease, Beijing China
    Clinics (Sao Paulo) 68:732-7. 2013
    ..Slow coronary flow syndrome is an important angiographic clinical entity with an unknown etiology. This study aimed to examine the relationship between red cell distribution width and the presence of slow coronary flow syndrome...
  2. pmc Evaluation of red blood cell distribution width in patients with cardiac syndrome X
    Ping Qing
    Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Dis Markers 34:333-9. 2013
    ..However, its pathogenesis has not fully been understood yet. Red blood cell distribution width (RDW) has recently been suggested as a marker of acute and chronic cardiovascular diseases, while no data is available in patients with CSX...
  3. pmc RANTES gene G-403A polymorphism and coronary artery disease: a meta analysis of observational studies
    Jun Liu
    Division of Dyslipidemia, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    PLoS ONE 7:e47211. 2012
    ..In order to shed some light on these inconsistent findings, a meta analysis was performed to clarify the role of G-403A polymorphism of RANTES gene in the susceptibility of CAD...
  4. ncbi Inflammation in coronary artery diseases
    Jian Jun Li
    Divison of Dyslipidemia, Cardiovascular Medicine, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 124:3568-75. 2011
    ....
  5. doi Impact of direct sirolimus-eluting stent implantation on the early systemic inflammatory response compared with complementary stent implantation
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China
    Coron Artery Dis 20:65-70. 2009
    ..Impact of DS on the early inflammatory response has, however, not been investigated. We hypothesized that a direct DES implantation may attenuate the early inflammatory response compared with CS...
  6. ncbi Is any link between inflammation and coronary artery ectasia?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 69:678-83. 2007
    ..Accordingly, more complete understanding of the pro- and anti-inflammatory circuits that operate during CAE in particular may foster the development of novel therapeutic approaches...
  7. doi Impact of Xuezhikang on coronary events in hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, P R China
    Ann Med 42:231-40. 2010
    ..The lowering of cholesterol concentrations in individuals at high risk for cardiovascular disease improves clinical outcome. Xuezhikang has a marked impact on lipids...
  8. ncbi Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 120:569-73. 2007
    ..Currently, two platforms of DES are available (sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES)). However, it has less been known that DES, SES vs PES, is superior for the treatment of small coronary lesions...
  9. ncbi Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People s Republic of China
    Coron Artery Dis 18:293-8. 2007
    ..In this study, we therefore evaluated the possible delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent...
  10. ncbi Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 69:333-7. 2007
    ..Accordingly, we hypotheses that these pleiotropic effects of statin may be beneficial for patients with slow coronary flow syndrome due to its pharmacological basis...
  11. ncbi Is inflammation a contributor for coronary stent restenosis?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    Med Hypotheses 68:945-51. 2007
    ..Measurement of cytokine and acute phase proteins, such as C-reactive protein, therefore, may be important to identify high-risk subjects and develop specific treatment tailored to the individual patients...
  12. ncbi Inflammation in variant angina: is there any evidence?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, People s Republic of China
    Med Hypotheses 68:635-40. 2007
    ..Although much more research is obviously needed, primary evidence provide us with some direction for that research...
  13. ncbi Reduction of C-reactive protein by a single 80 mg of simvastatin in patients with unstable angina
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    Clin Chim Acta 376:163-7. 2007
    ..We investigated whether a rapid CRP reduction can be achieved by a single 80 mg of simvastatin therapy in patients with UA given immediately on admission...
  14. ncbi Inflammation in hypertension: primary evidence
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 119:1215-21. 2006
  15. ncbi A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 119:1059-64. 2006
    ..The aim of the present study was to retrospectively compare angiographic and clinical outcomes after treatment of ISR with SES or PES in a series of consecutive patients with ISR...
  16. ncbi Increased plasma C-reactive protein and interleukin-6 concentrations in patients with slow coronary flow
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    Clin Chim Acta 385:43-7. 2007
    ..However, the possible association between inflammation and slow coronary flow (SCF) has not been investigated. We examined whether the increased inflammatory markers are present in patients with SCF...
  17. ncbi Elevated circulating inflammatory markers in female patients with cardiac syndrome X
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Cytokine 40:172-6. 2007
    ..However, despite the extensive studies, the precise mechanisms in cardiac syndrome X remain unclear...
  18. ncbi The role of inflammation in coronary artery calcification
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical College, Beijing 100037, PR China
    Ageing Res Rev 6:263-70. 2007
    ....
  19. doi Long-term effects of Xuezhikang on blood pressure in hypertensive patients with previous myocardial infarction: data from the Chinese Coronary Secondary Prevention Study (CCSPS)
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
    Clin Exp Hypertens 32:491-8. 2010
    ....
  20. pmc Impact of C-reactive protein on in-stent restenosis: a meta-analysis
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical College, Beijing 100037, China
    Tex Heart Inst J 37:49-57. 2010
    ....
  21. doi Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    J Clin Pharmacol 49:947-56. 2009
    ..This finding may have an important implication for the treatment of elderly hypertensive patients with CHD...
  22. doi Chronic inflammatory status in patients with coronary artery ectasia
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Cytokine 46:61-4. 2009
    ..The role of inflammation in atherosclerosis is increasingly well known. However, the association between inflammation and CAE has been controversial...
  23. doi Comparison of changes in early inflammatory markers between sirolimus- and paclitaxel-eluting stent implantation
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People s Republic of China
    Cardiovasc Drugs Ther 23:137-43. 2009
    ..However, the underlying mechanism for this disparity is not well investigated. We hypothesize that an attenuated inflammatory response after SES implantation may be a contributor...
  24. doi Randomized comparison of early inflammatory response after sirolimus-eluting stent vs bare metal stent implantation in native coronary lesions
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Clin Chim Acta 396:38-42. 2008
    ..We prospectively investigated the early inflammatory response after SES or BMS implantation in patients with single-vessel lesion, and evaluated the relationship between inflammation and late clinical outcomes in a randomized design...
  25. doi Increased peripheral circulating inflammatory cells and plasma inflammatory markers in patients with variant angina
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
    Coron Artery Dis 19:293-7. 2008
    ..However, the relation of inflammatory status to coronary vasospasm has been less investigated in patients with variant angina (VA)...
  26. ncbi Inflammatory response, drug-eluting stent and restenosis
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 121:566-72. 2008
  27. ncbi Angiographic prevalence of myocardial bridging in a defined very large number of Chinese patients with chest pain
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 121:405-8. 2008
    ..In addition, no similar study was reported in Chinese population. The aim of this study was to investigate the angiographic prevalence of MB in consecutive 37,106 Chinese patients with chest pain from our center...
  28. ncbi Effects of sirolimus-eluting stent on calcified coronary lesions
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 121:6-11. 2008
    ..In the present study, therefore, we evaluated the effectiveness of SES implantation for the treatment of calcified coronary lesions...
  29. ncbi Time course of rapid C-reactive protein reduction by pravastatin in patients with stable angina
    Jian Jun Li
    Renmin Hospital, Wuhan University School of Medicine, Wuhan, P R China
    Angiology 57:1-7. 2006
    ....
  30. ncbi Should slow coronary flow be considered as a coronary syndrome?
    Jian Jun Li
    Department of Cardiology, Center for Diagnosis and Treatment of Coronary Artery Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People s Republic of China
    Med Hypotheses 66:953-6. 2006
    ..In our opinion, slow coronary flow without evident cause may represent a new entity of coronary heart disease. Therefore, we would like to consider it as a syndrome, and call it as a "slow coronary flow syndrome"...
  31. ncbi Is slow coronary flow associated with inflammation?
    Jian Jun Li
    Center for Diagnosis and Treatment of Coronary Artery Disease, Fu Wai Hospital, Department of Cardiology, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 66:504-8. 2006
    ..Whether this is really a new kind of coronary disease involving in inflammation, however, is still unknown and deserves further investigation...
  32. ncbi Inflammation may be a bridge connecting hypertension and atherosclerosis
    Jian Jun Li
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Science and Cardiovascular Institute, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 64:925-9. 2005
    ..Based on those increasing evidence, we hypothesize that inflammation may be a bridge connecting hypertension and atherosclerosis...
  33. ncbi Variant angina in a 17-year-old male
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, People s Republic of China
    Acta Cardiol 60:69-71. 2005
    ..The patient has been asymptomatic since discharge, and treatment with calcium channel antagonists with nitrate seems to assure a good prognosis...
  34. ncbi Silent myocardial ischemia may be related to inflammatory response
    Jian Jun Li
    Heart Center, First Affiliated Hospital, Tsinghua University School of Medicine, JieFang 1, JiuXianQiao, Beijing 100016, PR China
    Med Hypotheses 62:252-6. 2004
    ..That is, pain perception may result from microenviromental balance between proinflammatory and anti-inflammatory cytokines...
  35. ncbi Enhancing anti-inflammatory cytokine IL-10 may be beneficial for acute coronary syndrome
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital and Cardiovascular Institute, Chinese Academy of Medical Science and Peking Union Medical College, Beilishi Road 167, Beijing 100037, People s Republic of China
    Med Hypotheses 65:103-6. 2005
    ..Therefore, we hypotheses that enhancing anti-inflammatory cytokine IL-10 may be a promising approach for the therapy of acute coronary diseases...
  36. ncbi Should atherosclerosis be considered a cancer of the vascular wall?
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, 167 Bei Li Shi Road, Beijing 100037, PR China
    Med Hypotheses 64:694-8. 2005
    ..In the future, it is likely that the shared features of atherosclerosis and cancer will not only become clinically significant but also stimulate therapeutic strategies for clinical applications...
  37. ncbi Effects of xuezhikang, an extract of cholestin, on lipid profile and C-reactive protein: a short-term time course study in patients with stable angina
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Clin Chim Acta 352:217-24. 2005
    ..We evaluated the short-term time course effects of lipid profile and CRP by Xuezhikang in patients with stable angina...
  38. ncbi Enhanced inflammatory response of blood monocytes to C-reactive protein in patients with unstable angina
    Jian Jun Li
    Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Clin Chim Acta 352:127-33. 2005
    ..Whether this enhanced inflammatory response also exists, however, in cultured monocytes from patients with unstable angina, in response to CRP, has not been investigated...
  39. ncbi C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases
    Jian Jun Li
    Remin Hospital, Wuhan University School of Medicine, Wuhan 430060, PR China
    Med Hypotheses 62:499-506. 2004
    ..Other interventions, such as lifestyle changes, weight loss, and stop smoking are also warrant attention...
  40. ncbi Is hypertension an inflammatory disease?
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan 430060, People s Republic of China
    Med Hypotheses 64:236-40. 2005
    ....
  41. ncbi Time course of inflammatory response after renal artery stenting in patients with atherosclerotic renal stenosis
    Jian Jun Li
    Renmin Hospital, Wuhan University School of Medicine, Wuhan 430060, PR China
    Clin Chim Acta 350:115-21. 2004
    ..Such response following renal artery stenting has not yet been established, however, in patients with atherosclerotic renal artery stenosis...
  42. ncbi Increased C-reactive protein level after renal stent implantation in patients with atherosclerotic renal stenosis
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, People s Republic of China
    Angiology 55:479-84. 2004
    ....
  43. ncbi A pedigree analysis of familial hypercholesterolemia in monozygote twin brothers
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan, People s Republic of China
    Angiology 54:711-3. 2003
    ..This pedigree analysis showed that FH appears to be a hereditary disease of autosomal dominance, and attention should be paid, especially in the only son or daughter society of China...
  44. ncbi Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis
    Jian Jun Li
    Benmin Hospital, Wuhan University School of Medicine, Wuhan 430060, PR China
    Med Hypotheses 63:100-2. 2004
    ..Based on evidence and in light of the new understanding that inflammation is an intrinsic part of the process, we would like to propose a further change of nomenclature, call the disease atheroscleritis...
  45. ncbi Inflammation: an important mechanism for different clinical entities of coronary artery diseases
    Jian Jun Li
    Center of Diagnosis and Treatment of Coronary Artery Disease, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 118:1817-26. 2005
  46. ncbi Changes of plasma inflammatory markers after withdrawal of statin therapy in patients with hyperlipidemia
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beilishi Road 167, Beijing 100037, People s Republic of China
    Clin Chim Acta 366:269-73. 2006
    ..We investigated whether acute termination of statin treatment could result in rebound of inflammatory markers, such as C-reactive protein (CRP) and interleukin-6 (IL-6), in patients with hyperlipidemia...
  47. ncbi Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, 238 Jiefang Road, Wuhan 430060, People s Republic of China
    Coron Artery Dis 14:329-34. 2003
    ..However, the effect of simvastatin on interleukin-6 (IL-6) release in cultured human monocytes was not investigated. DESIGN A prospective, human monocyte culture, simvastatin intervention study...
  48. ncbi Inflammation: a possible pathogenic link to cardiac syndrome X
    Jian Jun Li
    Center of Diagnosis and Treatment of Coronary Artery Disease, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    Med Hypotheses 66:87-91. 2006
    ....
  49. ncbi Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People s Republic of China
    Clin Chem 51:1735-8. 2005
  50. ncbi Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan, People s Republic of China
    Clin Cardiol 26:472-6. 2003
    ..Limited information has been available in evaluating a potentially effective first 2-week therapeutic approach for the treatment of patients with hypercholesterolemia using a statin...
  51. ncbi Ischemic preconditioning detected by treadmill exercise tests in patients with stable angina
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan, People s Republic of China
    Angiology 54:45-50. 2003
    ..In conclusion, the first ischemic event could induce the IP phenomenon and protect the heart from more serious damage at a 10-minute interval. However, this effect disappeared when the second test was done at a 60-minute interval...
  52. doi Impact of 10 mg rosuvastatin daily or alternate-day on lipid profile and inflammatory markers
    Jian Jun Li
    Division of Dyslipidemia, Cardiovascular Medicine, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
    Clin Chim Acta 413:139-42. 2012
    ..We evaluated the potential efficacy of alternate-day dosing of 10mg rosuvastatin compared with daily dosing of 10mg rosuvastatin with regarding to lipid and inflammatory markers in patients with dyslipidemia...
  53. doi Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts
    Yue jin Yang
    Center for Coronary Heart Disease, Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, 167 BeiLiShi Rd, Beijing, 100037, PR China
    Arterioscler Thromb Vasc Biol 29:2076-82. 2009
    ..Based on the pleiotropic beneficial effects of statins, we examined whether simvastatin (SIMV) increased the efficacy of mesenchymal stem cell (MSC) transplantation after AMI...
  54. doi Immediate and long-term outcomes of drug-eluting stent implantation for unprotected left main coronary artery disease: comparison with bare-metal stent implantation
    Run lin Gao
    Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical, College, Beijing, China
    Am Heart J 155:553-61. 2008
    ..The efficacy and safety of drug-eluting stent (DES) implantation for unprotected left main coronary artery (LMCA) disease remain to be established in different clinical settings...
  55. doi Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent
    Jue Chen
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
    Coron Artery Dis 19:507-11. 2008
    ..It is not known, however, which DES, sirolimus-eluting stent (SES) versus paclitaxel-eluting stent (PES), is superior for the treatment of ostial lesions...
  56. doi Treatment of mild-moderate calcified coronary lesions with sirolimus-eluting stent: real world data from a single center
    Jin qing Yuan
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, PR China
    Coron Artery Dis 21:33-8. 2010
    ..Therefore, we evaluated the effectiveness of SES implantation for the treatment of calcified lesions in a large Chinese cohort of real world practice...
  57. doi Transradial versus transfemoral method of percutaneous coronary revascularization for unprotected left main coronary artery disease: comparison of procedural and late-term outcomes
    Yue jin Yang
    Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    JACC Cardiovasc Interv 3:1035-42. 2010
    ..This study intended to compare outcomes between transradial (TR) and transfemoral (TF) percutaneous revascularization in high-risk coronary anatomy...
  58. doi Long-term clinical efficacy of cutting balloon angioplasty followed by bare metal stent implantation for treating ostial left anterior descending artery lesions
    Li Jian Gao
    Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People s Republic of China
    Clin Cardiol 32:E31-5. 2009
    ..Drug-eluting stents (DES) are superior to bare metal stents (BMS) for treating ostial left anterior descending artery (LAD) lesions, but DES is not suitable for all patients in real life practice...
  59. ncbi A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients
    Bo Xu
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 119:533-8. 2006
    ..However, no large-sample published studies are available on angiographic stent restenosis including those of bare-metal stent (BMS) or drug-eluting stent (DES) in Chinese Han ethnic population...
  60. ncbi Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients
    Sheng Kang
    Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 119:1157-64. 2006
    ..We compared the inpatient and 7-month follow-up outcomes between DES and BMS for the treatment of bifurcation lesions...
  61. ncbi Elevated level of plasma C-reactive protein in patients with unstable angina: its relations with coronary stenosis and lipid profile
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, People s Republic of China
    Angiology 53:265-72. 2002
    ....
  62. ncbi Effects of Tongxinluo-facilitated cellular cardiomyoplasty with autologous bone marrow-mesenchymal stem cells on postinfarct swine hearts
    Hai yan Qian
    Department of Cardiology, Fuwai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
    Chin Med J (Engl) 120:1416-25. 2007
    ....
  63. ncbi Age-based clinical and angiographic outcomes after sirolimus-eluting stent implantation in patients with coronary artery disease
    Bo Xu
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 120:447-51. 2007
    ....
  64. ncbi Effect of intracoronary infusion of bone marrow mononuclear cells or peripheral endothelial progenitor cells on myocardial ischemia-reperfusion injury in mini-swine
    Chong jian Li
    Center of Coronary Heart Disease, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med Sci J 25:176-81. 2010
    ..To simulate and assess the clinical effect of intracoronary infusion of bone marrow mononuclear cells or peripheral endothelial progenitor cells on myocardial reperfusion injury in mini-swine model...
  65. ncbi [Effects of sirolimus-eluting stent and the paclitaxel-eluting stent: a three-year follow-up study]
    Zhan Gao
    Coronary Heart Disease Division, Cardiovascular Institute and Fuwai Hospital, Peking Union Medical College and Chinese Academy of Medical Science, Beijing 100037, China
    Zhonghua Yi Xue Za Zhi 88:1811-4. 2008
    ..To compare the long-term effects of the China-made sirolimus-eluting stent (Firebird) and the imported paclitaxel-eluting stent (Taxus)...
  66. doi The accelerated post-infarction progression of cardiac remodelling is associated with genetic changes in an untreated streptozotocin-induced diabetic rat model
    Guang yuan Song
    Center of Coronary Heart Disease, Cardiovascular Institute and Fu Wai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, PR China
    Eur J Heart Fail 11:911-21. 2009
    ..We studied the severity of cardiac dysfunction and time-dependent gene expression in a hyperglycaemic rat model with AMI...
  67. ncbi A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results
    Hai bo Liu
    Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 120:574-7. 2007
    ..However, it is unclear whether there are differences in safety and efficacy between the two types of stents in daily practice...
  68. ncbi [Comparison of outcomes after transradial intervention in patients of different age groups]
    Sheng Wen Liu
    Coronary Heart Disease Center, Peking Union Medical College, Beijing 100037, China
    Zhonghua Yi Xue Za Zhi 90:2852-5. 2010
    ....
  69. ncbi Comparison of short- and long-term outcomes between Cypher and TAXUS drug-eluting stents for in-stent restenosis
    Ji lin Chen
    Center for Diagnosis and Treatment of Coronary Heart Disease, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037
    Chin Med Sci J 22:5-8. 2007
    ..To compare the short- and long-term clinical outcomes between sirolimus-eluting stent (Cypher stent) and paclitaxel-eluting stent (TAXUS stent) in patients with in-stent restenosis (ISR) lesions of the coronary arteries...
  70. ncbi Comparison of the incidence of late stent thrombosis after implantation of different drug-eluting stents in the real world coronary heart disease patients: three-year follow-up results
    Ji lin Chen
    Center for Coronary Heart Disease, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 123:778-81. 2010
    ..This study aimed to compare the incidence of LST after implantation of different drug-eluting stents (DES) in coronary heart disease (CHD) patients in the real world...
  71. doi Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway
    Jie Li
    Department of Cardiology, Cardiovascular Institute and Fu Wai Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100037, China
    Cardiovasc Ther 28:8-14. 2010
    ..This pathway might represent a promising target for controlling CRP-induced inflammatory response in pulmonary arterial diseases...
  72. ncbi Comparison of in-hospital and long-term outcomes between a Cypher stent and a Taxus stent in Chinese diabetic patients with coronary artery disease
    Yue jin Yang
    Coronary Heart Disease Center, Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Chin Med J (Engl) 120:1868-73. 2007
    ....
  73. ncbi Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts
    Yue jin Yang
    Department of Cardiology, Fu Wai Hospital and Cardiovascular Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, 167 BeiLiShi Rd, Beijing 100037, People s Republic of China
    Eur Heart J 29:1578-90. 2008
    ..To investigate whether Atorvastatin (Ator) treatment improves the cardiac micro-environment that facilitates survival and differentiation of bone-marrow-derived mesenchymal stem cells (MSCs) implanted in the post-infarct myocardium...
  74. ncbi Statin, like aspirin, should be given as early as possible in patients with acute coronary syndrome
    Chun Hong Fang
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan 430060, PR China
    Med Hypotheses 64:192-6. 2005
    ....
  75. ncbi Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin
    Wen Lan Hu
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, PR China
    Cytokine 40:201-6. 2007
    ..We hypothesize that CRP may result in overexpression of resistin, and statin may decrease CRP-induced resistin expression in cultured human peripheral blood monocytes (PBMC)...
  76. ncbi Comparison of drug-eluting stent and bare-mental stent in the complex small vessel intervention
    Shu Bin Qiao
    Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical University, Beijing 100037, China
    Chin Med J (Engl) 119:596-600. 2006
  77. ncbi [Effects of recombined pcDNA3.1-hBMP-2 transfection on human marrow stromal stem cells proliferation and vascular endothelial growth factor expression]
    Jian Jun Li
    Department of Orthopaedics, First Hospital of Jilin University, Changchun, Jilin, P R China 130021
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 18:100-3. 2004
    ..1-hBMP-2 and transfect into human marrow stromal stem cells (MSCs) in vitro, and to explore the effects of transfection on cellular proliferation and expression of vascular endothelial growth factor (VEGF)...
  78. ncbi [Microbial community composition and phylogenetic analysis of deodor biofilter under different pH conditions]
    Tong Sheng Chen
    Guangdong Institute of Microbiology, Guangdong Provincial Key Laboratory of Microbial Culture Collection and Application, Guangzhou 510070, China
    Wei Sheng Wu Xue Bao 45:446-50. 2005
    ..The research offers the valid scientific basis for better treatment of odorant gas and the theoretical foundation for application of bio-deodorization...
  79. ncbi Rebound phenomenon of inflammatory response may be a major mechanism responsible for increased cardiovascular events after abrupt cessation of statin therapy
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People s Republic of China
    Med Hypotheses 66:1199-204. 2006
    ..This finding may be of important interest in the connection between inflammatory response and abrupt withdrawal of statin therapy in patients with coronary artery disease...
  80. pmc Short- and long-term outcomes of single bare metal stent versus drug eluting stent in nondiabetic patients with a simple de novo lesion in the middle and large vessel
    Yue jin Yang
    Department of Cardiology, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Bei Li Shi Rd 167, Beijing, 100037, PR China
    J Transl Med 6:42. 2008
    ....
  81. ncbi Effect of angiotensin II receptor 1 antisense oligodoexynucleotides on physiological and pathophysiological growth of cardiomyocytes
    Ying Wang
    Department of Cardiology, Renmin Hospital, Wuhan University, Wuhan 430060, China
    Acta Pharmacol Sin 25:561-9. 2004
    ..To evaluate the role of angiotensin II receptor 1 antisense oligodexynucleotides (AT1R-AS-ODNs) on physiological and pathophysiological growth of cardiomyocytes from normotensive rats...
  82. ncbi [Different effects of inflammation and lipid levels on coronary lesions after PCI]
    Hai Yan Xu
    Fuwai Cardiovascular Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Zhonghua Yi Xue Za Zhi 89:2249-52. 2009
    ..To assess the different effects of inflammation and lipid levels before and after PCI on in-stent restenosis and lesion progression...
  83. ncbi Decreased infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the anti-atherogenic effects of losartan
    Hong Xin Xu
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, People s Republic of China
    Acta Cardiol 62:607-13. 2007
    ....
  84. ncbi Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein
    Hai rong Wang
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, 238 Jiefang Road, Wuhan 430060, People s Republic of China
    Clin Chim Acta 353:53-60. 2005
    ..We determined the effects of CRP in inducing inflammatory response and the effect of fluvastatin on CRP-dependent inflammatory activation in human cultured endothelial cells...
  85. ncbi Coronary restenotic reduction of drug-eluting stenting may be due to its anti-inflammatory effects
    Jian Jun Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing 100037, PR China
    Med Hypotheses 69:1004-9. 2007
    ....
  86. ncbi Circadian variation in myocardial ischemia: the possible mechanisms involving in this phenomenon
    Jian Jun Li
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan, People s Republic of China
    Med Hypotheses 61:240-3. 2003
    ..This information should enable better understanding as well as treatment on patients on circadian variation of cardiovascular events...
  87. ncbi A rational connection of inflammation with peripheral arterial disease
    Jie Li
    Department of Cardiology, Fu Wai Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, People s Republic of China
    Med Hypotheses 69:1190-5. 2007
    ..All of those evidences indicate that PAD is one aspect of atherosclerosis, a disease rationally connects with inflammation, which may further change our preventive and therapeutic strategies...
  88. ncbi Diverse effects of long-term treatment with imidapril and irbesartan on cell growth signal, apoptosis and collagen type I expression in the left ventricle of spontaneously hypertensive rats
    Jin Ming Wang
    Department of Cardiology, Renmin Hospital, Wuhan University School of Medicine, Wuhan 430060, People s Republic of China
    Life Sci 75:407-20. 2004
    ..Irbesartan is more effective in regressing the homeostasis between ERK-1 and MKP-1, however imidapril is superior in suppressing apoptosis and collagen synthesis in cardiac tissue...
  89. ncbi Comparison of immediate and followup results between transradial and transfemoral approach for percutaneous coronary intervention in true bifurcational lesions
    Yue jin Yang
    Centre for Coronary Artery Disease, Department of Cardiology, Cardiovascular Institute and Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
    Chin Med J (Engl) 120:539-44. 2007
    ..This study evaluated feasibility of transradial PCI (TRI) and compared the immediate and followup results with transfemoral PCI (TFI) in bifurcations...
  90. ncbi Effects of fenofibrate on inflammatory cytokines and blood pressure in patients with hypertriglyceridemia
    Ping Ye
    Clin Chim Acta 356:229-32. 2005
  91. ncbi [Effects of components isolated from Astragalus mongholicus on expression of p-selectin in shock wave induced kidney injury in rabbit model]
    Xiang Li
    Institute of Urology, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi an Jiaotong University, Xi an 710061, China
    Zhongguo Zhong Yao Za Zhi 30:1606-9. 2005
    ..To investigate the effective components of Astragalus mongholicus and their mechanisms in alleviating extracorporeal shock wave lithotripsy (ESWL) induced kidney injury...
  92. ncbi Xuezhikang, an extract of cholestin, decreases plasma inflammatory markers and endothelin-1, improve exercise-induced ischemia and subjective feelings in patients with cardiac syndrome X
    Jian Jun Li
    Int J Cardiol 122:82-4. 2007
    ..Data suggested that the benefit of Xuezhikang resulted in significant modification vascular function by reduction of ET-1, inflammatory markers and LDL cholesterol, which may be clinically important for patients with CSX...